Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

LABORATOIRE ASTELIA : revenue, balance sheet and financial ratios

LABORATOIRE ASTELIA is a French company founded 7 years ago, specialized in the sector Fabrication de préparations pharmaceutiques. Based in MANOSQUE (04100), this company of category PME shows in 2024 a net income positive of 108 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - LABORATOIRE ASTELIA (SIREN 851020560)
Indicator 2024
Revenue N/C
Net income 108 138 €
EBITDA N/C
Net margin N/C

Revenue and income statement

In 2024, LABORATOIRE ASTELIA generates positive net income of 108 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

108 138 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 84%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 45%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

83.622%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

44.941%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

88.4%

Solvency indicators evolution
LABORATOIRE ASTELIA

Sector positioning

Debt ratio
83.62 2024
2024
Q1: 0.0
Med: 5.92
Q3: 43.75
Watch

In 2024, the debt ratio of LABORATOIRE ASTELIA (83.62) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
44.94% 2024
2024
Q1: 28.05%
Med: 51.52%
Q3: 72.2%
Average

In 2024, the financial autonomy of LABORATOIRE ASTELIA (44.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 488.79. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

488.789

Liquidity indicators evolution
LABORATOIRE ASTELIA

Sector positioning

Liquidity ratio
488.79 2024
2024
Q1: 120.09
Med: 209.86
Q3: 363.93
Excellent

In 2024, the liquidity ratio of LABORATOIRE ASTELIA (488.79) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of LABORATOIRE ASTELIA in its sector

Comparison with sector Fabrication de préparations pharmaceutiques

Valuation estimate

Indicative estimate only : the number of comparable transactions in this sector is limited (27 transactions). This range of 21 575€ to 66 315€ is provided for information purposes only and requires in-depth analysis to be confirmed.

Estimated enterprise value 2024
Indicative
21k€ 48k€ 66k€
48 711 € Range: 21 575€ - 66 315€
NAF 5 all-time
How is this estimate calculated?

This estimate is based on the analysis of 27 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Fabrication de préparations pharmaceutiques)

Compare LABORATOIRE ASTELIA with other companies in the same sector:

Voir toutes les statistiques du secteur Fabrication de préparations pharmaceutiques

Frequently asked questions about LABORATOIRE ASTELIA

What is the revenue of LABORATOIRE ASTELIA ?

The revenue of LABORATOIRE ASTELIA is not publicly disclosed (confidential accounts filed with INPI).

Is LABORATOIRE ASTELIA profitable?

Yes, LABORATOIRE ASTELIA generated a net profit of 108 k€ in 2024.

Where is the headquarters of LABORATOIRE ASTELIA ?

The headquarters of LABORATOIRE ASTELIA is located in MANOSQUE (04100), in the department Alpes-de-Haute-Provence.

Where to find the tax return of LABORATOIRE ASTELIA ?

The tax return of LABORATOIRE ASTELIA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does LABORATOIRE ASTELIA operate?

LABORATOIRE ASTELIA operates in the sector Fabrication de préparations pharmaceutiques (NAF code 21.20Z). See the 'Sector positioning' section above to compare the company with its competitors.